Gary F. Lewis

Toronto Public Health — Canada

Medicine · Health Sciences

70h-index17.5kcitations234works1.42yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Diabetes, Cardiovascular Risks, and Lipoproteins(69), Lipid metabolism and disorders(43), Pancreatic function and diabetes(41), Diet, Metabolism, and Disease(33), Metabolism, Diabetes, and Cancer(32)

Publications233 total

Massive Tissue Deposition of Cholesterol Leading to Multi-Organ Failure in Cholestatic Hypercholesterolemia
Canadian Journal of Diabetes·2025
P306 HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA IN CANADA: 2025 REGISTRY UPDATE
Canadian Journal of Cardiology·2025
P274 SOCIODEMOGRAPHIC AND CLINICAL CHARACTERISTICS ASSOCIATED WITH RECEIPT OF LP(A) TESTING IN ONTARIO: A POPULATION-BASED CROSS-SECTIONAL ANALYSIS
Canadian Journal of Cardiology·2025
Serotonin, a downstream effector of GLP-2, enhances lacteal contractility and lymph flow
American Journal of Physiology-Gastrointestinal and Liver Physiology·2025Open Access
Massive tissue deposition of cholesterol leading to multi-organ failure in cholestatic hypercholesterolemia
Journal of Clinical and Translational Endocrinology Case Reports·2025Open Access
Contemporary experience of aortic stenosis in the Canadian homozygous familial hypercholesterolemia registry
Atherosclerosis·2025
MAIT Cells in Lipoprotein Metabolism: A New Pathway for VLDL Clearance?
Circulation Research·2025· 1 cited
Futility of plasmapheresis, insulin in normoglycaemic individuals, or heparin in the treatment of hypertriglyceridaemia-induced acute pancreatitis
The Lancet Diabetes & Endocrinology·2025· 12 cited
Activation of VEGFR3 and MLC2 are Critical for GLP-2 Enhancement of Chylomicron Transport
Gastro Hep Advances·2024· 1 citedOpen Access
Fatty acid malabsorption followed by chylomicron malformation, not pancreatic insufficiency, cause metabolic defects in cystic fibrosis
Journal of Lipid Research·2024Open Access
The Complexities of Intestinal Lipoprotein Production in Insulin Resistance and Diabetes: Revisiting a 2010 <i>Diabetes</i> Classic by Pavlic et al.
Diabetes·2024Open Access
Glucagon-Like-Peptide-2 Stimulates Lacteal Contractility and Enhances Chylomicron Transport in the Presence of an Intact Enteric Nervous System
Gastro Hep Advances·2024· 3 citedOpen Access
Unanticipated Enhancement of Intestinal TG Output by Apoc3 ASO Inhibition
Arteriosclerosis Thrombosis and Vascular Biology·2023· 3 cited
Glucagon-like Peptide-2 Acutely Enhances Chylomicron Secretion in Humans Without Mobilizing Cytoplasmic Lipid Droplets
The Journal of Clinical Endocrinology & Metabolism·2022· 7 cited
An Analysis of Risk Factors for Radiation Necrosis Following Cranial Radiation
Cureus·2022· 1 citedOpen Access
Enteral glucose, absorbed and metabolized, potently enhances mesenteric lymph flow in chow- and high-fat-fed rats
American Journal of Physiology-Gastrointestinal and Liver Physiology·2022· 4 cited
Recent advances in cytoplasmic lipid droplet metabolism in intestinal enterocyte
Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids·2022· 10 cited
Glucagon-like peptide-2 mobilization of intestinal lipid does not require canonical enterocyte chylomicron synthetic machinery
Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids·2022· 9 cited
Insights and Strategies to Revive Brachytherapy Using Social Media: A Google Trends Analysis
Cureus·2022· 3 citedOpen Access
Lymphatics - not just a chylomicron conduit
Current Opinion in Lipidology·2022· 6 cited
page 1 of 12Next →

Frequent Co-authors

Adria Giacca(14), Changting Xiao(13), André C. Carpentier(11), Khosrow Adeli(8), Kristine D. Uffelman(7), Linda Szeto(6), Benoı̂t Lamarche(5), Satya Dash(5), Robert A. Hegele(4), Changiz Taghibiglou(4), Stephen C. Van Iderstine(4), Cecilia Morgantini(4), George Steiner(3), Shirya Rashid(3), K. S. Polonsky(3), I. George Fantus(2), Andrew Mente(2), Mahshid Dehghan(2), Sumathy Rangarajan(2), Rafael Díaz(2)